Innovation
12 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady.
Social engagement
Social engagement: 1.8K social following, 10 posts in the last 12 months — below the industry typical range.
Recent activity
2 Jul 2026
Leadership hire
Spinogenix Scientific Advisory Board member
16 Jun 2026
Product launch
tazbentetol
4 Jun 2026
Event
FRAXA Research Foundation webinar on Fragile X Treatment pipeline